RxDoctor Payments Data

Edda Didonato, NP

Nurse Practitioner · Georgetown, DENPI 1306253281

Payments from drug & device makers

$1,203in general payments, 2019–2025

Across 66 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$384
  • Novartis$136
  • Lilly USA, LLC$118
  • Exact Sciences$104
  • Dexcom, Inc.$87
  • AstraZeneca$67
  • plus $307 from 12 others

What the payments were for

  • Food & beverage$1,203100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,203 in reported general payments places this provider in the 80th percentile of 487 nurse practitioner providers in Delaware.

See all nurse practitioner providers in Delaware

Medicare billing

Part B allowed, 2024
$51,595
Medicare patients
92
Services billed
544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin21$29,061
TradjentaLinagliptin11$14,067
Breo ElliptaFluticasone/Vilanterol11$3,956
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,529
Atorvastatin Calcium231$2,638
Losartan Potassium158$2,139
Hydralazine Hcl61$1,426
Amlodipine Besylate216$1,287
Bisoprolol Fumarate37$1,083
Omeprazole71$1,077
Fluticasone Propionate54$884
Levothyroxine Sodium94$870
Lisinopril104$802
Pravastatin Sodium31$662
NitrofurantoinNitrofurantoin Macrocrystal12$610

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$27$43,12832 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$87094 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 487 nurse practitioner providers in Delaware.

Other nurse practitioner in Georgetown

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →